 Eastman Kodak Co NYSE: KODK CEO Jim Continenza said Monday that the company would push ahead with making generic drug ingredients, irrespective of whether it receives government assistance or not, the Wall Street Journal reports. What Happened: It was put on hold but we are still going forward and we are cooperating in every way, Continenza said at the WSJ Tech Live conference on the stalled 765 million loan deal with the United States government. 